范
范秀莲 Chief Executive Officer
C-suite
FR FR · AMF
Discover the full record of transactions filed by 范秀莲, Chief Executive Officer. Officer active across 1 companies, notably 海思科. Cumulatively, 18 disclosures have been published. Regulator: AMF. All data is openly available.
Declarations 18 total
Executives ● Sale米 米奥会展 11 SZSE 30,000 shares
SZSE:173000009718138620 · 5 Nov 2025
1,921,000 shares
SZSE:173000007201516740 · 29 Dec 2023
Executives ● Sale米 米奥会展 7 SZSE 80,000 shares
SZSE:173000006758872800 · 25 Jul 2023
Executives ● Sale海 海思科 10 SZSE 1,140,000 shares
SZSE:173000006588598720 · 11 May 2023
Executives ● Sale海 海思科 10 SZSE 500,000 shares
SZSE:173000006579405630 · 8 May 2023
Executives ● Sale海 海思科 10 SZSE 8,515,000 shares
SZSE:173000006546687780 · 27 Apr 2023
Executives ● Sale海 海思科 10 SZSE 400,000 shares
SZSE:173000006536417250 · 26 Apr 2023
Executives ● Sale米 米奥会展 11 SZSE 5,100 shares
SZSE:173000006105738560 · 2 Dec 2022
Executives ● Sale米 米奥会展 14 SZSE 10,800 shares
SZSE:173000006004962400 · 1 Nov 2022
Executives ● Purchase东 东北制药 25 SZSE 36,000 shares
SZSE:173000005558279000 · 31 May 2022
Ideal exit: 25 Feb 2023 (T+270) Executives ● Purchase东 东北制药 22 SZSE 100 shares
SZSE:173000005553620700 · 25 May 2022
Ideal exit: 19 Feb 2023 (T+270) Executives ● Purchase东 东北制药 11 SZSE 11,000 shares
SZSE:173000005542938500 · 20 May 2022
Ideal exit: 14 Feb 2023 (T+270) Executives ● Purchase东 东北制药 11 SZSE 18,600 shares
SZSE:173000005539586050 · 19 May 2022
Ideal exit: 13 Feb 2023 (T+270) Executives ● Purchase东 东北制药 11 SZSE 19,700 shares
SZSE:173000005491264160 · 28 Apr 2022
Ideal exit: 23 Jan 2023 (T+270) Executives ● Purchase东 东北制药 18 SZSE 50,000 shares
SZSE:173000005173966850 · 15 Dec 2021
Ideal exit: 11 Sept 2022 (T+270) Executives ● Purchase东 东北制药 7 SZSE 30,000 shares
SZSE:173000005167089500 · 13 Dec 2021
Ideal exit: 9 Sept 2022 (T+270) Executives ● Purchase东 东北制药 7 SZSE 110,000 shares
SZSE:173000005118990820 · 29 Nov 2021
Ideal exit: 26 Aug 2022 (T+270) Executives ● Purchase东 东北制药 22 SZSE 3,200 shares
SZSE:173000005118990720 · 29 Nov 2021
Ideal exit: 26 Aug 2022 (T+270) About 范秀莲 Fan Xiulian is the Chief Executive Officer of Haike Science, where he oversees the company's operations and strategy. With significant experience in the sector, he has played a key role in optimizing processes and improving efficiency. His leadership focuses on innovation and sustainability.